S'abonner

Postmortem microfocus computed tomography for early gestation fetuses: a validation study against conventional autopsy - 28/03/18

Doi : 10.1016/j.ajog.2018.01.040 
John C. Hutchinson, MBBS a, c, Xin Kang, MD d, Susan Cheng Shelmerdine, MBBS b, c, Valerie Segers, MD e, Claudio M. Lombardi, MD g, Mieke M. Cannie, MD, PhD f, h, Neil J. Sebire, MD, PhD a, c, Jacques C. Jani, MD, PhD d, Owen J. Arthurs, MD, PhD b, c,
a Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, UK 
b Department of Paediatric Radiology, Great Ormond Street Hospital for Children NHS Trust, London, UK 
c UCL Great Ormond Street Institute of Child Health 
d Department of Obstetrics and Gynaecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium 
e Department of Histopathology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium 
f Department of Radiology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium 
g Department of Radiology, Studio Diagnostico Eco, Vimercate, Milan, Italy 
h Department of Radiology, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium 

Corresponding author: Owen J. Arthurs, MD, PhD.

Abstract

Background

Perinatal autopsy provides useful clinical information in up to 40% of cases. However, there is a substantial unmet clinical need with regards to postmortem investigation of early gestation fetal loss for parents for whom standard autopsy is either not available or not acceptable. Parents dislike the invasive nature of autopsy, but current clinical imaging techniques do not provide high-enough imaging resolution in small fetuses. We hypothesized that microfocus computed tomography, which is a rapid high-resolution imaging technique, could give accurate diagnostic imaging after early gestation fetal loss.

Objective

The objective of the study was to evaluate the diagnostic accuracy of microfocus computed tomography for noninvasive human fetal autopsy for early gestation fetuses, with the use of conventional autopsy as the reference standard.

Study Design

We compared iodinated whole body microfocus computed tomography in 20 prospectively recruited fetuses (11–21 weeks gestation from 2 centers) with conventional autopsy in a double-blinded manner for a main diagnosis and findings in specific body organs. Fetuses were prepared with 10% formalin/potassium tri-iodide. Images were acquired with a microfocus computed tomography scanner with size-appropriate parameters. Images were evaluated independently by 2 pediatric radiologists, who were blinded to formal perinatal autopsy results, across 40 individual indices to reach consensus. The primary outcome was agreement between microfocus computed tomography and conventional autopsy for overall diagnosis.

Results

Postmortem whole body fetal microfocus computed tomography gave noninvasive autopsy in minutes, at a mean resolution of 27μm, with high diagnostic accuracy in fetuses at <22 weeks gestation. Autopsy demonstrated that 13 of 20 fetuses had structural abnormalities, 12 of which were also identified by microfocus computed tomography (92.3%). Overall, microfocus computed tomography agreed with overall autopsy findings in 35 of 38 diagnoses (15 true positive, 18 true negative; sensitivity 93.8% [95% confidence interval, 71.7–98.9%], specificity 100% [95% confidence interval, 82.4–100%]), with 100% agreement for body imaging diagnoses. Furthermore, after removal of nondiagnostic indices, there was agreement for 700 of 718 individual body organ indices that were assessed on microfocus computed tomography and autopsy (agreement, 97.5%; 95% confidence interval, 96.1–98.4%), with no overall differences between fetuses at ≤14 or >14 weeks gestation (agreement, 97.2% and 97.9%, respectively). Within first-trimester fetal loss cases (<14 weeks gestation), microfocus computed tomography analysis yielded significantly fewer nondiagnostic indices than autopsy examination (22/440 vs 48/348, respectively; P<.001).

Conclusion

Postmortem whole-body fetal microfocus computed tomography gives noninvasive, detailed anatomic examinations that are achieved in minutes at high resolution. Microfocus computed tomography may be preferable to magnetic resonance imaging in early gestation fetuses and may offer an acceptable method of examination after fetal loss for parents who decline invasive autopsy. This will facilitate autopsy and subsequent discussions between medical professionals who are involved in patient care and counselling for future pregnancies.

Le texte complet de cet article est disponible en PDF.

Key words : autopsy, microfocus computed tomography, postmortem, termination of pregnancy


Plan


 Supported by an RCUK/UKRI Innovation Fellowship and Medical Research Council Clinical Research Training Fellowship (grant ref: MR/R00218/1), which is an award that is jointly funded by the Royal College of Radiologists (S.C.S.); by a National Institute for Health Research (NIHR) Clinician Scientist Fellowship awards (NIHR-CS-012-002; O.J.A.) and an NIHR Senior Investigator award (N.J.S,); by funding from the Great Ormond Street Hospital Children’s Charity and NIHR GOSH Biomedical Research Centre (O.J.A., N.J.S., and J.C.H.); and in part by the Pathological Society of Great Britain and Northern Ireland (J.C.H.). Part of this work was supported by the Fetal Medicine Foundation Belgium.
 This article presents independent research funded by the NIHR, and the views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health. None of the funders were involved in the design or interpretation of the results.
 The authors report no conflict of interest.
 Cite this article as: Hutchinson JC, Kang X, Shelmerdine SC, et al. Postmortem microfocus computed tomography for early gestation fetuses: a validation study against conventional autopsy. Am J Obstet Gynecol 2018;218:445.e1-12.


© 2018  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 218 - N° 4

P. 445.e1-445.e12 - avril 2018 Retour au numéro
Article précédent Article précédent
  • Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa
  • Yaakov Melcer, Eric Jauniaux, Shlomit Maymon, Anna Tsviban, Marina Pekar-Zlotin, Moshe Betser, Ron Maymon
| Article suivant Article suivant
  • Subsequent fertility, pregnancy, and gynecologic outcomes after fetoscopic laser therapy for twin-twin transfusion syndrome compared with normal monochorionic twin gestations
  • Simen Vergote, Liesbeth Lewi, Willem Gheysen, Luc De Catte, Roland Devlieger, Jan Deprest

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.